SSA
PHAS

Schonfeld Strategic Advisors’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PHAS Stock Details PHAS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
2022
Q1 		$34K Buy
2019
Q4 		– Sell
2019
Q3 		$220K Sell
2019
Q2 		$1.19M Buy
2019
Q1 		$600K Buy